Should I buy or sell Definitive Healthcare stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares. View DH analyst ratings or view top-rated stocks .

What is Definitive Healthcare's stock price target for 2024?

9 equities research analysts have issued 1-year price objectives for Definitive Healthcare's shares. Their DH share price targets range from $9.50 to $15.00. On average, they expect the company's share price to reach $11.31 in the next twelve months. This suggests a possible upside of 61.6% from the stock's current price. View analysts price targets for DH or view top-rated stocks among Wall Street analysts .

How have DH shares performed in 2024?

Definitive Healthcare's stock was trading at $9.94 at the start of the year. Since then, DH stock has decreased by 29.6% and is now trading at $7.00. View the best growth stocks for 2024 here .

Are investors shorting Definitive Healthcare?

Definitive Healthcare saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 7,440,000 shares, an increase of 54.0% from the March 15th total of 4,830,000 shares. Based on an average daily volume of 554,800 shares, the days-to-cover ratio is presently 13.4 days. Currently, 15.6% of the shares of the company are sold short. View Definitive Healthcare's Short Interest .

When is Definitive Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our DH earnings forecast .

How were Definitive Healthcare's earnings last quarter?

Definitive Healthcare Corp. (NASDAQ:DH) issued its earnings results on Wednesday, February, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.01 by $0.02. The firm had revenue of $65.93 million for the quarter, compared to analysts' expectations of $66.01 million. Definitive Healthcare had a negative net margin of 80.40% and a positive trailing twelve-month return on equity of 0.43%.

What ETFs hold Definitive Healthcare's stock?

ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Alger Weatherbie Enduring Growth ETF (AWEG) , Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC) . First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) .

What guidance has Definitive Healthcare issued on next quarter's earnings?

Definitive Healthcare updated its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of 0.070-0.080 for the period, compared to the consensus estimate of 0.070. The company issued revenue guidance of $63.0 million-$65.0 million, compared to the consensus revenue estimate of $65.7 million.

When did Definitive Healthcare IPO?

Definitive Healthcare (DH) raised $350 million in an initial public offering on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share.

How do I buy shares of Definitive Healthcare?

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:DH

Definitive Healthcare (DH) Stock Price, News & Analysis

→ The #1 Opportunity of the decade? (From Behind the Markets) (Ad)

Free DH Stock Alerts

$7.06

+0.02 (+0.28%)

(As of 04:00 PM ET)

Compare

Today's Range: $6.97
▼
$7.08
50-Day Range: $7.04
▼
$10.26
52-Week Range: $5.53
▼
$12.45

Volume: 532,994 shs
Average Volume: 574,901 shs
Market Capitalization: $831.60 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $11.31

Get Definitive Healthcare alerts:

Definitive Healthcare MarketRank™ Stock Analysis

Analyst Rating: Hold
2.30 Rating Score
Upside/Downside: 61.6% Upside
$11.31 Price Target
Short Interest: Bearish
15.57% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.94
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 27.27%
From $0.11 to $0.14 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.72 out of 5 stars

Medical Sector

535th out of 918 stocks

Prepackaged Software Industry

146th out of 197 stocks

3.1

Analyst's Opinion

Consensus Rating
Definitive Healthcare has received a consensus rating of Hold. The company's average rating score is 2.22, and is based on 2 buy ratings, 7 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Definitive Healthcare has only been the subject of 2 research reports in the past 90 days.

0.0

Short Interest

Percentage of Shares Shorted
15.57% of the float of Definitive Healthcare has been sold short.
Short Interest Ratio / Days to Cover
Definitive Healthcare has a short interest ratio ("days to cover") of 13.4, which indicates bearish sentiment.
Change versus previous month
Short interest in Definitive Healthcare has recently increased by 54.04%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Definitive Healthcare does not currently pay a dividend.
Dividend Growth
Definitive Healthcare does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for DH.

3.3

News and Social Media Coverage

News Sentiment
Definitive Healthcare has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Definitive Healthcare this week, compared to 2 articles on an average week.
Search Interest
4 people have searched for DH on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Definitive Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Definitive Healthcare insiders have not sold or bought any company stock.
Percentage Held by Insiders
15.27% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
98.67% of the stock of Definitive Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Definitive Healthcare are expected to grow by 27.27% in the coming year, from $0.11 to $0.14 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Definitive Healthcare is -3.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Definitive Healthcare is -3.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Definitive Healthcare has a PEG Ratio of 6.26. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Definitive Healthcare has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Behind the Markets

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

About Definitive Healthcare Stock (NASDAQ:DH)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.

DH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DH Stock News Headlines

April 16, 2024 | finance.yahoo.com

Definitive Healthcare introduces Carevoyance sales enablement solution for medtech industry

April 13, 2024 | americanbankingnews.com

Head-To-Head Analysis: Xunlei (NASDAQ:XNET) vs. Definitive Healthcare (NASDAQ:DH)

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

March 22, 2024 | markets.businessinsider.com

VML and Definitive Healthcare announce partnership to transform key opinion leader management

March 22, 2024 | globenewswire.com

VML and Definitive Healthcare announce partnership to transform key opinion leader management

March 21, 2024 | markets.businessinsider.com

Needham Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)

March 20, 2024 | morningstar.com

Definitive Healthcare Corp Class A

March 19, 2024 | seekingalpha.com

Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

March 16, 2024 | finance.yahoo.com

DH Apr 2024 5.000 put

March 16, 2024 | finance.yahoo.com

DH Jul 2024 5.000 put

March 14, 2024 | globenewswire.com

Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal

March 2, 2024 | finance.yahoo.com

Definitive Healthcare Corp. (NASDAQ:DH) Just Released Its Annual Earnings: Here's What Analysts Think

March 1, 2024 | markets.businessinsider.com

Hold Rating on Definitive Healthcare Amid Leadership Changes and Revenue Uncertainties

March 1, 2024 | markets.businessinsider.com

What 4 Analyst Ratings Have To Say About Definitive Healthcare

February 29, 2024 | markets.businessinsider.com

Maintaining Hold on Definitive Healthcare Corp Amidst Transition and Mixed Growth Signals

February 29, 2024 | markets.businessinsider.com

Challenging Times For Definitive Healthcare: Analysts Highlight Sluggish Growth And Recovery Efforts In Q4 Analysis

February 29, 2024 | finanznachrichten.de

Definitive Healthcare Corp.: Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023

February 28, 2024 | seekingalpha.com

Definitive Healthcare Corp. 2023 Q4 - Results - Earnings Call Presentation

February 28, 2024 | msn.com

Definitive Healthcare reports Q4 results

February 28, 2024 | finance.yahoo.com

Definitive Healthcare Corp Reports Mixed Results Amidst Growth and Challenges

February 28, 2024 | globenewswire.com

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023

February 27, 2024 | benzinga.com

Earnings Outlook For Definitive Healthcare

February 17, 2024 | finance.yahoo.com

DH Mar 2024 10.000 call

February 14, 2024 | finance.yahoo.com

Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast

February 14, 2024 | globenewswire.com

Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast

January 17, 2024 | realmoney.thestreet.com

Definitive Healthcare just downgraded at Needham, here's why

See More Headlines

Receive DH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/28/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Prepackaged software
Sub-Industry: N/A
Current Symbol: NASDAQ:DH
CUSIP: N/A
CIK: 1861795
Web: www.definitivehc.com
Phone: 508-720-4224
Fax: N/A
Employees: 950
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $11.31
High Stock Price Target: $15.00
Low Stock Price Target: $9.50
Potential Upside/Downside: +60.7%
Consensus Rating: Hold
Rating Score (0-4): 2.30
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.78)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 64.00
P/E Growth: 6.26
Net Income: $-202,390,000.00
Net Margins: -80.40%
Pretax Margin: -122.58%
Return on Equity: 0.43%
Return on Assets: 0.29%

Debt

Debt-to-Equity Ratio: 0.20
Current Ratio: 2.31
Quick Ratio: 2.31

Sales & Book Value

Annual Sales: $251.41 million
Price / Sales: 3.30
Cash Flow: $3.03 per share
Price / Cash Flow: 2.32
Book Value: $10.31 per share
Price / Book: 0.68

Miscellaneous

Outstanding Shares: 117,790,000
Free Float: 99,803,000
Market Cap: $829.24 million
Optionable: Not Optionable
Beta: 1.39

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Jason Ronald Krantz (Age 50)
Founder, Executive Chairman & Interim CEO
Comp: $820.92k
Mr. Jon Maack
President
Mr. Richard Douglas Booth (Age 55)
Chief Financial Officer
Comp: $562.44k
Ms. Kate Marie Shamsuddin Jensen (Age 38)
Chief Product Officer
Comp: $393.26k
Mr. Scott Oberlink
Chief Technology Officer
Mr. Matt Ruderman
Chief Legal Officer & Secretary
Mr. Craig Hazenfield
Chief People Officer
Mr. Ram Sharma
Executive Vice President of Life Sciences
Ms. Carrie Lazorchak
Chief Revenue Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

DH Stock Analysis - Frequently Asked Questions

Should I buy or sell Definitive Healthcare stock right now?: 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares.
View DH analyst ratings or view top-rated stocks.
What is Definitive Healthcare's stock price target for 2024?: 9 equities research analysts have issued 1-year price objectives for Definitive Healthcare's shares. Their DH share price targets range from $9.50 to $15.00. On average, they expect the company's share price to reach $11.31 in the next twelve months. This suggests a possible upside of 61.6% from the stock's current price.
View analysts price targets for DH or view top-rated stocks among Wall Street analysts.
How have DH shares performed in 2024?: Definitive Healthcare's stock was trading at $9.94 at the start of the year. Since then, DH stock has decreased by 29.6% and is now trading at $7.00.
View the best growth stocks for 2024 here.
Are investors shorting Definitive Healthcare?: Definitive Healthcare saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 7,440,000 shares, an increase of 54.0% from the March 15th total of 4,830,000 shares. Based on an average daily volume of 554,800 shares, the days-to-cover ratio is presently 13.4 days. Currently, 15.6% of the shares of the company are sold short.
View Definitive Healthcare's Short Interest.
When is Definitive Healthcare's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our DH earnings forecast.
How were Definitive Healthcare's earnings last quarter?: Definitive Healthcare Corp. (NASDAQ:DH) issued its earnings results on Wednesday, February, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.01 by $0.02. The firm had revenue of $65.93 million for the quarter, compared to analysts' expectations of $66.01 million. Definitive Healthcare had a negative net margin of 80.40% and a positive trailing twelve-month return on equity of 0.43%.

What ETFs hold Definitive Healthcare's stock?: ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Alger Weatherbie Enduring Growth ETF (AWEG), Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).
What guidance has Definitive Healthcare issued on next quarter's earnings?: Definitive Healthcare updated its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of 0.070-0.080 for the period, compared to the consensus estimate of 0.070. The company issued revenue guidance of $63.0 million-$65.0 million, compared to the consensus revenue estimate of $65.7 million.
When did Definitive Healthcare IPO?: Definitive Healthcare (DH) raised $350 million in an initial public offering on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share.
How do I buy shares of Definitive Healthcare?: Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial